255 results Stibbe advises biotech company Stibbe advised a leading biotechnology company on the legal aspects of clinical trials development for biotech medicinal products. Stibbe advises major pharmaceutical company Stibbe assisted a global innovative pharmaceutical company in a complex co-marketing and co-promotion agreement and advised it on the impact of an innovative product’s registration at the European Medicines Agency. Stibbe advises on the IPO of Tornier Stibbe advises Cellerix Stibbe assisted Cellerix with its merger with Euronext-Brussels-listed Tigenix. Investeren in muziekrechten; financieel interessant, maar ook juridisch houdbaar? Investeren in muziekrechten is trending. Dit artikel onderzoekt hoe Nederlandse muziekrechten zich juridisch lenen voor investeringen door professionele beleggers, met focus op uitdagingen van het Nederlandse recht. ESG risk management: developments in the Dutch and EU financial sector What ESG risk rules are coming for EU/Dutch financial firms? DNB’s new climate risk Guide for insurers, pension funds, and payment firms aligns with EBA ESG Guidelines. This blog explains how both shape the future of EU ESG risk management. Roderik Vrolijk Partner Amsterdam Stibbe assists New Mountain Capital Stibbe assisted New Mountain Capital with Luxembourg legal aspects related to the signing of a purchase agreement pursuant to which Grant Thornton Luxembourg will join a new transatlantic professional services platform led by Grant Thornton Advisors LLC. Rogier Raas Partner Amsterdam Listing Act: reversing MiFID II's unbundling regime – is it enough? The Listing Act rolls back the unbundling requirements introduced by MiFID II by once again permitting joint payments for investment research and execution services. In this article, we address the background and practical implications of this amendment. Buy the dip! Toezicht en handhaving op finfluencers In een nieuwe aflevering van onze podcast Stibbe Legal Insights duiken we in de wereld van finfluencers: online persoonlijkheden die beleggingsadvies geven of financiële producten aanprijzen via social media. Cross-border corporate lending into the Netherlands Cross-border corporate lending is set for change as CRD VI introduces new licensing obligations, requiring non-EU lenders to reassess their activities in the Netherlands and the EU for all in scope contracts signed on or after 11 July 2026. Vince Van der Wangen Associate Brussels European Commission Updates High-Risk Third Countries List The European Commission adopted a Delegated Regulation (EU/2025/1184) amending its list of high-risk third countries under the Anti-Money Laundering and Anti-Terrorism Financing Directive. The Netherlands Implements EU Non-Performing Loan Directive The Dutch Implementation Act on Credit Servicers and Credit Purchasers entered into force on 18 July 2025. It implements EU Directive 2021/2167 regulating NPL sale, purchase and servicing to create a transparent secondary market. Tom Barkhuysen Partner Amsterdam Tom Barkhuysen Partner Amsterdam Anna Collignon Partner Amsterdam Pagination Previous page Page 12 Page 13 Current page 14 Page 15 Next page
Stibbe advises biotech company Stibbe advised a leading biotechnology company on the legal aspects of clinical trials development for biotech medicinal products.
Stibbe advises major pharmaceutical company Stibbe assisted a global innovative pharmaceutical company in a complex co-marketing and co-promotion agreement and advised it on the impact of an innovative product’s registration at the European Medicines Agency.
Stibbe advises Cellerix Stibbe assisted Cellerix with its merger with Euronext-Brussels-listed Tigenix.
Investeren in muziekrechten; financieel interessant, maar ook juridisch houdbaar? Investeren in muziekrechten is trending. Dit artikel onderzoekt hoe Nederlandse muziekrechten zich juridisch lenen voor investeringen door professionele beleggers, met focus op uitdagingen van het Nederlandse recht.
ESG risk management: developments in the Dutch and EU financial sector What ESG risk rules are coming for EU/Dutch financial firms? DNB’s new climate risk Guide for insurers, pension funds, and payment firms aligns with EBA ESG Guidelines. This blog explains how both shape the future of EU ESG risk management.
Stibbe assists New Mountain Capital Stibbe assisted New Mountain Capital with Luxembourg legal aspects related to the signing of a purchase agreement pursuant to which Grant Thornton Luxembourg will join a new transatlantic professional services platform led by Grant Thornton Advisors LLC.
Listing Act: reversing MiFID II's unbundling regime – is it enough? The Listing Act rolls back the unbundling requirements introduced by MiFID II by once again permitting joint payments for investment research and execution services. In this article, we address the background and practical implications of this amendment.
Buy the dip! Toezicht en handhaving op finfluencers In een nieuwe aflevering van onze podcast Stibbe Legal Insights duiken we in de wereld van finfluencers: online persoonlijkheden die beleggingsadvies geven of financiële producten aanprijzen via social media.
Cross-border corporate lending into the Netherlands Cross-border corporate lending is set for change as CRD VI introduces new licensing obligations, requiring non-EU lenders to reassess their activities in the Netherlands and the EU for all in scope contracts signed on or after 11 July 2026.
European Commission Updates High-Risk Third Countries List The European Commission adopted a Delegated Regulation (EU/2025/1184) amending its list of high-risk third countries under the Anti-Money Laundering and Anti-Terrorism Financing Directive.
The Netherlands Implements EU Non-Performing Loan Directive The Dutch Implementation Act on Credit Servicers and Credit Purchasers entered into force on 18 July 2025. It implements EU Directive 2021/2167 regulating NPL sale, purchase and servicing to create a transparent secondary market.